| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |